Session » Pediatric Rheumatology – Pathogenesis and Genetics Poster

Date: Tuesday, November 7, 2017

Time: 9:00AM-11:00AM

Meeting: 2017 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 2327

14-3-3η (eta) Protein in Juvenile Idiopathic Arthritis (JIA) Patients

9:00AM-11:00AM: Abstract Number: 2343

A Genome-Wide Association Study Suggests the HLA Class II Region As the Major Susceptibility Locus for IgA Vasculitis

9:00AM-11:00AM: Abstract Number: 2348

A New Cause of Mendelian Lupus Due to IKZF1 Mutation Underlines the B Cell Landscape Heterogeneity in Monogenic Lupus

9:00AM-11:00AM: Abstract Number: 2333

Adjudication of Infections from the Pharmacovigilance in Juvenile Idiopathic Arthritis Patients (PHARMACHILD) Treated with Biologic Agents and/or Methotrexate with a Focus on Opportunistic Infections

9:00AM-11:00AM: Abstract Number: 2335

Antiendothelial Cell Antibodies in Juvenile Dermatomyositis: A Proteomics-Based Approach

9:00AM-11:00AM: Abstract Number: 2332

Biomarkers for the Diagnosis and the Identification of Risk of Macrophage Activation Syndrome (MAS) in Systemic Juvenile Idiopathic Arthritis (sJIA)

9:00AM-11:00AM: Abstract Number: 2344

Cell-Bound Complement Activation Products As Markers of Disease Flares in Childhood Onset Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 2328

Characterisation of Lipid Mediator Profile and Immune Cells in Synovial Fluid of Juvenile Idiopathic Arthritis

9:00AM-11:00AM: Abstract Number: 2345

Characterization of Adenosine Deaminase 2 Variants Identified in an International Pediatric Vasculitis Cohort

9:00AM-11:00AM: Abstract Number: 2346

Chemokine Ligand 9 (CXCL9) [Monokine Induced By Gamma Interferon (MIG)] As a Predictor of Active Disease Status in Localized Scleroderma

9:00AM-11:00AM: Abstract Number: 2340

Correlation of Type I Interferon Score and CXCL10 (C-X-C Motif Chemokine Ligand 10) with Cutaneous and Muscular Disease Activity in Juvenile Dermatomyositis Patients

9:00AM-11:00AM: Abstract Number: 2330

Evidence for Alternatively Activated (M2) Macrophage Activation in Patients with Enthesitis Related Arthritis Category of Juvenile Idiopathic Arthritis

9:00AM-11:00AM: Abstract Number: 2323

Exploring HLA-DRB1 Risk Alleles in Non-Hispanic African American Children with Juvenile Idiopathic Arthritis and Chronic Anterior Uveitis

9:00AM-11:00AM: Abstract Number: 2336

Expression of Myxovirus-Resistance Protein a: A Possible Marker of Muscular Disease Activity in Juvenile Dermatomyositis

9:00AM-11:00AM: Abstract Number: 2339

Expression of Type I and Type II Interferons Is Increased in Muscle Biopsies of Juvenile Dermatomyositis Patients and Related to Clinical and Histological Features

9:00AM-11:00AM: Abstract Number: 2325

Extensive Serum Cytokine Analysis in Patients with Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis

9:00AM-11:00AM: Abstract Number: 2350

Gastrointestinal Microbiota in New-Onset Juvenile Idiopathic Arthritis

9:00AM-11:00AM: Abstract Number: 2347

High Interferon (IFN) Signatures and Overlapping Clinical Features Characterize Subgroups of Patients with Presumed IFN-Mediated Autoinflammatory Diseases

9:00AM-11:00AM: Abstract Number: 2334

Hypermethylation of NLRP3 Promoter Region Could be Responsible for Decreased Gene Expression, Inflammasome Malfunction and Gut Dysbiosis in Juvenile Spondyloarthritis Patients

9:00AM-11:00AM: Abstract Number: 2349

Interferon Signature in Childhood Rheumatic Diseases

9:00AM-11:00AM: Abstract Number: 2326

Modeling Transcriptional Rewiring in Neutrophils through the Course of Treated Juvenile Idiopathic Arthritis

9:00AM-11:00AM: Abstract Number: 2329

Monocytes from Patients with Enthesitis Related Arthritis Produce High Levels of Pro-Inflammatory Cytokines: Role of Endogenous Ligands

9:00AM-11:00AM: Abstract Number: 2331

Next Generation Sequencing Analysis of Familial Haemophagocytic Lymphohistiocytosis (HLH) Related Genes in Macrophage Activation Syndrome (MAS) and Secondary HLH (sHLH)

9:00AM-11:00AM: Abstract Number: 2337

Novel Serum Broad-Based Proteomic Discovery Analysis Identifies Proteins and Pathways Dysregulated in Juvenile Dermatomyositis (JDM) and Myositis Autoantibody Groups

9:00AM-11:00AM: Abstract Number: 2338

Plasma Exosomes from Children with Juvenile Dermatomyositis Are Taken up By Human Aortic Endothelial Cells and Are Associated with Altered Gene Expression in Those Cells

9:00AM-11:00AM: Abstract Number: 2322

Quantitative Proteomics Comparison of Children with Inactive and Active Uveitis

9:00AM-11:00AM: Abstract Number: 2324

Single Cell RNA-Sequencing of Bone Marrow Macrophages Identifies a Distinct Subpopulation in Systemic JIA with Features of Interferon Response, Endocytic Vesicles and Phagocytosis

9:00AM-11:00AM: Abstract Number: 2341

The Interaction between Genetic Risk Factors and Age of Disease Onset in Juvenile Dermatomyositis

9:00AM-11:00AM: Abstract Number: 2342

Transcriptomic Analysis Reveals Mitochondrial and Monocyte Dysfunctions Are Linked to the Interferonopathy of Juvenile Dermatomyositis

« View all sessions from this meeting